Affordable Access

deepdyve-link
Publisher Website

RETRACTED: Identification of an antitumor immune response of polyhistidine through a toll-like receptor 4-dependent manner.

Authors
  • Wang, Feng1
  • Yang, Yong2
  • 1 Department of Gastroenterology, The Tenth People's Hospital of Shanghai, Tongji University, Shanghai 200072, PR China; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA. , (China)
  • 2 Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: [email protected]
Type
Published Article
Journal
Biochemical and Biophysical Research Communications
Publisher
Elsevier
Publication Date
Oct 10, 2014
Volume
453
Issue
1
Pages
148–152
Identifiers
DOI: 10.1016/j.bbrc.2014.09.078
PMID: 25264106
Source
Medline
Keywords
License
Unknown

Abstract

Polyhistidine is widely used for the delivery of nucleic acids and antibodies into the cell cytoplasm. However, little attention has been concerned on the effect of polyhistidine on the immune system. In this work, we identify a novel function of polyhistidine as an activator of the immune system. Single-molecule fluorescence imaging and single-molecule force measurements show that polyhistidine binds specifically to the toll-like receptor 4 (TLR4), inducing receptor dimerization and activation. Moreover, in a B16 melanoma model we demonstrate that polyhistidine treatment inhibits tumor growth in TLR4(+/+) but not TLR4(-/-) mice. These results suggest the potential use of polyhistidine for cancer immunotherapy.

Report this publication

Statistics

Seen <100 times